Trial
NCT04741542
Safety of SP-420 in the Treatment of Transfusional Iron Overload
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
Abfero Pharmaceuticals, Inc
Condition
Iron Overload
Intervention
SP-420
Why stopped
Study is on hold by FDA in the US.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-27